US6013853A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Continuous release polymeric implant carrier
Assignee: The University of Texas System
•
Filing: 1994-02-15
•
Granted: 2000-01-11
•
Expires: 2014-02-15
Abstract
Abstract Biodegradable, porous, polymeric implant material provides substantially continuous release of bioactive agent during in vivo use. Bioactive agent is initially released in amounts that are less than degradation rate of polymer, thereby promoting migration of cells into material. Later larger amounts of bioactive agent is released, thereby promoting differentiation of cells. Method of making material includes step of applying vacuum to form pores. Implant material may be adapted for one phase implant (e.g., for bone or cartilage) or for two phase layered implant (e.g., for cartilage layer on top of bone layer).
Inventors
- 👤 Kyriacos A Athanasiou
- 👤 Barbara D Boyan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 21:09
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/02; A61F2/28; A61F2/08; A61F2/10; A61F2/30; A61F2/30756; A61L; A61L31/00; A61L31/14; A61L31/146; A61L31/148; A61F2/3094; A61F2/0077; A61F2002/0086; A61F2/0811; A61F2002/0876; A61F2002/0888; A61F2002/2817; A61F2002/2835; A61F2002/2839; A61F2002/30001; A61F2002/30003; A61F2002/30004; A61F2002/30011; A61F2002/30014; A61F2002/30032; A61F2002/3006; A61F2002/30062; A61F2002/30108; A61F2002/30199; A61F2002/30224; A61F2002/30667; A61F2002/30677; A61F2/30767; A61F2002/3093; A61F2002/30971; A61F2210/00; A61F2210/0004; A61F2210/0085; A61F2230/00; A61F2230/0063; A61F2230/0069; A61F2240/00; A61F2240/001; A61F2250/00; A61F2250/0014; A61F2250/0018; A61F2250/0023; A61F2250/003
Claims Analysis
Total Claims: 38
Claim 1
Independent Claim
74 words
An implant material comprising a biodegradable, porous and polymeric material having a pore size between about 50 μm and about 200 μm, and at least about 50% by volume porosity, the implant material comprising a bioactive agent substantially uniformly incorporated therein such that, when the implant material is used in an in vivo environment, the implant material provides a substantially smooth continuous release of the bioactive agent during the first two weeks of use.
Claim 2
Dependent Claim
74 words
An implant material comprising a biodegradable, porous and polymeric material having a pore size between about 50 μm and about 200 μm, and at least about 50% by volume porosity, the implant material comprising a bioactive agent substantially uniformly incorporated therein such that, when the implant material is used in an in vivo environment, the implant material provides a substantially smooth continuous release of the bioactive agent during the first two weeks of use.
Claim 3
Dependent Claim
33 words
The polymeric implant material of claim 1 wherein the percentage degradation of the polymeric implant material is greater than the percentage release of the bioactive agent during the first two weeks of use.
Claim 4
Dependent Claim
25 words
The polymeric implant material of claim 2 wherein less than about 25% of the bioactive agent is released during the first two weeks of use.
Claim 5
Dependent Claim
25 words
The polymeric implant material of claim 2 wherein less than about 10% of the bioactive agent is released during the first two weeks of use.
Claim 6
Dependent Claim
29 words
The polymeric implant material of claim 2 wherein the average molecular weight of the implant is reduced by at least about 30% during the first two weeks of use.
Claim 7
Dependent Claim
47 words
The polymeric implant material of claim 2 wherein the average molecular weight of the implant is reduced by at least about 30% during the first two weeks of use, and less than about 10% of the bioactive agent is released during the first two weeks of use.
Claim 8
Dependent Claim
36 words
The polymeric implant material of claim 1 wherein the surface axial strain of the polymeric implant material after four weeks of use is greater than the surface axial strain of the polymeric implant material before use.
Claim 9
Dependent Claim
54 words
The polymeric implant material of claim 1 wherein the surface axial strain of the polymeric implant material after four weeks of use is greater than the surface axial strain of the polymeric implant material before use, and less than about 10% of the bioactive agent is released during the first two weeks of use.
Claim 10
Dependent Claim
17 words
The polymeric implant material of claim 1 wherein the polymeric implant material has a substantially uniform composition.
Claim 11
Dependent Claim
24 words
The polymeric implant material of claim 1 wherein the bioactive agent is adapted to be smoothly released during the first eight weeks of use.
Claim 12
Dependent Claim
31 words
The polymeric implant material of claim 1 wherein the bioactive agent is released such that a graph of cumulative release of the bioactive agent versus time depicts a substantially sigmoidal curve.
Claim 13
Dependent Claim
13 words
The polymeric implant material of claim 1 wherein the bioactive agent is hydrophobic.
Claim 14
Dependent Claim
14 words
The polymeric implant material of claim 1 wherein the bioactive agent is a polypeptide.
Claim 15
Dependent Claim
14 words
The polymeric implant material of claim 1 wherein the bioactive agent is an enzyme.
Claim 16
Dependent Claim
14 words
The polymeric implant material of claim 1 wherein the bioactive agent is a cytokine.
Claim 17
Dependent Claim
15 words
The polymeric implant material of claim 1 wherein the bioactive agent is a growth factor.
Claim 18
Dependent Claim
16 words
The polymeric implant material of claim 1 wherein the bioactive agent comprises transforming growth factor-β (TGF-β).
Claim 19
Dependent Claim
45 words
The polymeric implant material of claim 16 wherein the growth factor is selected from the group consisting of platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), basic fibroblast growth factor (bFGF), thyroid-derived chondrocyte stimulating factor (TDCSF), and bone morphogenic protein (BMP).
Claim 20
Dependent Claim
17 words
The polymeric implant material of claim 1 wherein the polymer is a copolymer of PLA and PGA.
Claim 21
Dependent Claim
18 words
The polymeric implant material of claim 19 wherein the copolymer is a 50:50 copolymer of PLA and PGA.
Claim 22
Dependent Claim
26 words
The polymeric implant material of claim 19 wherein the copolymer has an average molecular weight between about 10 kD and about 100 kD prior to use.
Claim 23
Dependent Claim
22 words
The polymeric material of claim 19 wherein the copolymer has an average molecular weight between about 40 kD and about 70 kD.
Claim 24
Dependent Claim
25 words
The polymeric implant material of claim 1 wherein the polymeric implant material has stress properties which are substantially comparable to the stress properties of cartilage.
Claim 25
Dependent Claim
25 words
The polymeric implant material of claim 1 wherein the polymeric implant material has compressibility properties which are substantially comparable to the compressibility properties of cartilage.
Claim 26
Dependent Claim
24 words
The polymeric implant material of claim 1 wherein the polymeric implant material has a porosity which is substantially comparable to the porosity of cartilage.
Claim 27
Dependent Claim
25 words
The polymeric implant material of claim 1 wherein the polymeric implant material has stress properties which are substantially comparable to the stress properties of bone.
Claim 28
Dependent Claim
25 words
The polymeric implant material of claim 1 wherein the polymeric implant material has compressibility properties which are substantially comparable to the compressibility properties of bone.
Claim 29
Dependent Claim
24 words
The polymeric implant material of claim 1 wherein the polymeric implant material has a porosity which is substantially comparable to the porosity of bone.
Claim 30
Dependent Claim
72 words
An implant material comprising a biodegradable, porous and polymeric material, the implant material comprising a bioactive agent substantially uniformly incorporated therein such that, when the implant material is used in an in vivo environment, the implant material provides a substantially smooth continuous release of the bioactive agent during the first two weeks of use, said implant material further comprising serum albumin present at less than about 100 μg per μg bioactive agent.
Claim 31
Dependent Claim
72 words
An implant material comprising a biodegradable, porous and polymeric material, the implant material comprising a bioactive agent substantially uniformly incorporated therein such that, when the implant material is used in an in vivo environment, the implant material provides a substantially smooth continuous release of the bioactive agent during the first two weeks of use, said implant material further comprising serum albumin present at less than about 100 μg per μg bioactive agent.
Claim 32
Dependent Claim
28 words
The polymeric implant material of claim 1 wherein the structure is adapted to release the bioactive agent during use over a period of at least about six weeks.
Claim 33
Dependent Claim
25 words
The polymeric implant material of claim 1 comprising between about 0.01 ng and about 1 mg of bioactive agent per milliliter of polymeric implant material.
Claim 34
Dependent Claim
23 words
The polymeric implant material of claim 1 comprising a plurality of passages having a diameter between about 1.0 mm and about 2.0 mm.
Claim 35
Dependent Claim
45 words
The polymeric implant material of claim 1 wherein the polymeric implant material is adapted to initially release the bioactive agent such that sufficient bioactive agent is present to promote migration of mesenchymal cells into the polymeric implant material without causing substantial differentiation of chondrocyte cells.
Claim 36
Dependent Claim
36 words
The polymeric implant material of claim 33 wherein the polymeric implant material is adapted such that after the initial release the material releases sufficient bioactive agent to promote differentiation of cells within the polymeric implant material.
Claim 37
Dependent Claim
27 words
The polymeric implant material of claim 1 comprising a plurality of bioactive agents, the bioactive agents being adapted to release in different amounts at different time periods.
Claim 38
Dependent Claim
47 words
A two-phase layered biodegradable implant, each layer comprising a biodegradable polymeric implant material of claim 1, wherein the first layer has stress properties substantially comparable to the stress properties of cartilage and wherein the second layer has stress properties substantially comparable to the stress properties of bone.
References Cited (Backward Citations)
DE1745676B1
Cited
US3620218A
Cited
US3739773A
Cited
US3887699A
Cited
US3773919A
Cited
US3755558A
Cited
US3991766A
Cited
US3976071A
Cited
US4076798A
Cited
US4011312A
Cited
US4048256A
Cited
US4095600A
Cited
US4118470A
Cited
US4122129A
Cited
US4756862A
Cited
US4261969A
Cited
US4622244A
Cited
US4293539A
Cited
US4346709A
Cited
US4767628A
Cited
US5004602A
Cited
US4767628B1
Cited
US4553272A
Cited
US4460562A
Cited
US4532123A
Cited
US4801739A
Cited
US5286763A
Cited
US4818542A
Cited
US4650488A
Cited
US4886870A
Cited
WO1986000526A1
Cited
US4705039A
Cited
US4652264A
Cited
US4997440A
Cited
WO1987000059A1
Cited
US5160490A
Cited
US4962091A
Cited
US4832686A
Cited
WO1988003417A1
Cited
US5084051A
Cited
US5041138A
Cited
US4968317A
Cited
US4968317B1
Cited
EP0277678A1
Cited
US4963489A
Cited
US4883666A
Cited
US4874388A
Cited
US4897268A
Cited
US4947840A
Cited
GB2209937A
Cited
EP0326426A2
Cited
US5053050A
Cited
US5100668A
Cited
US5032508A
Cited
GB2234896A
Cited
US5134122A
Cited
US5152791A
Cited
WO1991009079A1
Cited
US5492697A
Cited
US5290271A
Cited
EP0473268A2
Cited
WO1992011844A1
Cited
WO1992011843A1
Cited
US5206023A
Cited
WO1992014749A1
Cited
WO1993001315A1
Cited
US5270300A
Cited
US5464440A
Cited
WO1993015767A1
Cited
WO1993015694A1
Cited
US5342348A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2003-01-10 | 2003-07-12 | 2004-01-11 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2007-01-10 | 2007-07-12 | 2008-01-11 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2011-01-10 | 2011-07-12 | 2012-01-11 | $7700.00 | Window Closed / Lapsed |